Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOM3355 for Chorea in Huntington's Disease
NCT03575676Phase 2Completed
- Sponsor
- SOM Biotech
- Start
- Aug 2018
- Primary completion
- Aug 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of bevantolol in Huntington's disease (HD), sponsored by SOM Biotech. Started Aug 2018; status: completed.
02
Drugs
bevantolol
03
Conditions
Huntington's disease (HD)
Beyond the preview
Go deeper on NCT03575676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03575676.